Incannex Healthcare Inc. (IXHL) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2026, Incannex Healthcare reported revenue of $0, down 100.0% from $86,000 the year before. Net income was -$19.3M, or -$1.66 per diluted share. Operating activities generated -$12.9M of cash, leaving -$12.9M of free cash flow. At fiscal year end, Incannex Healthcare held $73.0M in total assets against $5.6M in total liabilities, including $67.7M of cash and equivalents.
Open the full interactive Incannex Healthcare financials → Quarterly statements, key ratios, valuation history and price charts.
Incannex Healthcare Key Stats
| Share Price | $2.91 |
|---|---|
| Market Cap | $33.9M |
| Revenue YoY Growth | -100.0% |
| 52-Week Range | $2.56 – $14.37 |
| Shares Outstanding | 11.7 million (basic, 2026 Q4) |
Incannex Healthcare Income Statement
| FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|
| Revenue | $12,000 | $86,000 | $0 |
| Operating Income | -$30.0M | -$23.8M | -$23.0M |
| Pre-Tax Income | -$18.4M | -$46.9M | -$19.3M |
| Income Tax | $30,000 | — | $0 |
| Net Income | -$18.5M | -$46.9M | -$19.3M |
| Diluted EPS | -$34.50 | -$40.50 | -$1.66 |
Incannex Healthcare Quarterly Results
| 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | |
|---|---|---|---|---|
| Net Income | -$6.4M | -$6.5M | -$3.9M | -$2.5M |
| Diluted EPS | -$0.60 | -$0.60 | -$0.35 | -$0.21 |
Incannex Healthcare Balance Sheet
| FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|
| Cash & Equivalents | $5.9M | $15.0M | $67.7M |
| Current Assets | $16.2M | $20.0M | $72.8M |
| Total Assets | $17.0M | $20.4M | $73.0M |
| Current Liabilities | $5.6M | $7.0M | $1.5M |
| Total Liabilities | $5.8M | $7.1M | $5.6M |
| Shareholders' Equity | $11.2M | $13.4M | $67.4M |
Incannex Healthcare Cash Flow Statement
| FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|
| Cash From Operations | -$15.8M | -$12.5M | -$12.9M |
| Cash From Investing | -$277,000 | -$8,000 | -$94,000 |
| Cash From Financing | — | $21.4M | $65.9M |
| Free Cash Flow | -$16.1M | -$12.5M | -$12.9M |
Figures from Incannex Healthcare's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Incannex Healthcare financials page for every line item.
Incannex Healthcare Company Profile
| Ticker | IXHL |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Norwest Nsw |
| Incorporated in | Delaware |
| Fiscal Year End | June 30 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0001873875 |
Frequently Asked Questions
What was Incannex Healthcare's revenue in fiscal 2026?
Incannex Healthcare (IXHL) reported revenue of $0 for fiscal 2026.
What is Incannex Healthcare's annual revenue history?
Incannex Healthcare's annual revenue by fiscal year: 2024: $12,000; 2025: $86,000; 2026: $0.
What was Incannex Healthcare's net income in fiscal 2026?
Incannex Healthcare reported net income of -$19.3M for fiscal 2026.
What was Incannex Healthcare's earnings per share (EPS) in fiscal 2026?
Incannex Healthcare's diluted EPS was -$1.66 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Incannex Healthcare generate in fiscal 2026?
Incannex Healthcare generated -$12.9M of free cash flow in fiscal 2026.
How many shares of Incannex Healthcare are outstanding?
Incannex Healthcare reported a weighted average of 11.7 million basic shares outstanding in 2026 Q4.
What is Incannex Healthcare's market cap?
Based on its latest closing price, Incannex Healthcare (IXHL) has a market capitalization of about $33.9M.
When does Incannex Healthcare's fiscal year end?
Incannex Healthcare's fiscal year end, as registered with the SEC, is June 30.
Where is Incannex Healthcare headquartered?
Incannex Healthcare lists its business address in Norwest Nsw in its SEC filings.